Catalyst Pharmaceuticals Stock Price - CPRX

0.14 (2.69%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Catalyst Pharmaceuticals Inc CPRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.01 0.19% 5.21 5.00 5.27 5.20 5.20 19:34:48
Bid Price Ask Price Spread Spread % News
5.23 5.35 0.12 2.24% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
15,610 2,256,820 $ 5.15 $ 11,630,612 1,734,594 2.235 - 7.67
Last Trade Time Type Quantity Stock Price Currency
19:41:51 49 $ 5.35 USD

Catalyst Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 536.88M 103.05M $ -34.00M -0.34 65.00 93.86M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Catalyst Pharmaceuticals News

Loading Messages....

Latest CPRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CPRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.895.284.765.082,032,1170.326.54%
1 Month4.205.283.844.561,578,3421.0124.05%
3 Months4.645.283.644.302,200,2640.5712.28%
6 Months6.207.673.644.922,310,592-0.99-15.97%
1 Year2.807.672.2354.572,227,4352.4186.07%
3 Years1.167.671.083.731,421,5244.05349.14%
5 Years3.377.670.513.311,172,2751.8454.6%

Catalyst Pharmaceuticals Description

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.